SKI Market

Indian Indices

Sensex

84,180.96 -780.18
( -0.92%)

Global Indices

Nasdaq

49,008.56 -474.53
(-0.96%)

Dow Jones

6,942.66 -23.16
(-0.33%)

Hang Seng

51,148.76 -813.22
(-1.57%)

Nikkei 225

10,039.39 -83.34
(-0.82%)

Forex

USD-INR

90.15 -0.06
(-0.07%)

EUR-INR

105.56 0.04
(0.04%)

GBP-INR

121.94 0.39
(0.32%)

JPY-INR

0.58 0.00
(0.08%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shree Ganesh Biotech India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539470

INE051N01026

1.5954132

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

27.51

EPS(TTM)

Face Value()

Div & Yield %

Back

W H Brady & Co consolidated net profit declines 69.51% in the September 2025 quarter

Nov 13,2025

Net profit of W H Brady & Co declined 69.51% to Rs 1.00 crore in the quarter ended September 2025 as against Rs 3.28 crore during the previous quarter ended September 2024. Sales declined 37.67% to Rs 16.81 crore in the quarter ended September 2025 as against Rs 26.97 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	16.81	26.97	-38
OPM %	8.74	14.42	-
PBDT	1.90	5.98	-68
PBT	1.22	5.49	-78
NP	1.00	3.28	-70

84,180.96 -780.18 ( -0.92%)

49,008.56 -474.53 (-0.96%)

6,942.66 -23.16 (-0.33%)

51,148.76 -813.22 (-1.57%)

10,039.39 -83.34 (-0.82%)

90.15 -0.06 (-0.07%)

105.56 0.04 (0.04%)

121.94 0.39 (0.32%)

0.58 0.00 (0.08%)